News
BIOMARK ANNOUNCES CLOSING OF $1.9 MILLION NON-BROKERED PRIVATE PLACEMENT
BIOMARK ANNOUNCES CLOSING OF $1.9 MILLION NON-BROKERED PRIVATE PLACEMENT Vancouver, British Columbia – (December 29th,
January 10, 2024
Menu
Menu
- News
BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
Articles and Information
Form 7 Monthly Progress Report December 2023
Form 7 Monthly Progress Report December 2023 Name of Listed Issuer: Trading Symbol: Number of
January 10, 2024
News
insightscare Interview: BioMark Diagnostics Inc: Innovating Cancer Detection
BioMark Diagnostics Inc: Innovating Cancer Detection From the interview originally published by insightscare https://insightscare.com/biomark-diagnostics-inc-innovating-cancer-detection/ Rashid
December 28, 2023
News
BIOMARK ANNOUNCES RECENT NEW PATENT GRANTED IN CANADA TO SUPPORT ITS LIQUID BIOPSY BASED LEGACY ASSAY
BIOMARK ANNOUNCES RECENT NEW PATENT GRANTED IN CANADA TO SUPPORT ITS LIQUID BIOPSY BASED LEGACY
December 4, 2023
Articles and Information
Form 7 Monthly Progress Report November 2023
Form 7 Monthly Progress Report November 2023 Name of Listed Issuer: Trading Symbol: Number of
December 4, 2023
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Pages
Latest Posts
Menu
Site Policies
Menu